The American Cancer Society (ACS) is advising providers to offer the Human Papillomavirus (HPV) vaccine starting at age 9 or 10. This is in adaption to the current Advisory Committee on Immunization Practices (ACIP) recommendation and in response to ACS’s review of several new studies showing the potential benefits of administering the vaccine at an earlier age. The HPV vaccine helps prevent cervical, oropharyngeal, anal, vaginal, vulvar, and penile cancers caused by HPV.
